These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 8530878)

  • 21. Exposure to host or fungal PGE₂ abrogates protection following immunization with Candida-pulsed dendritic cells.
    Kundu G; Noverr MC
    Med Mycol; 2011 May; 49(4):380-94. PubMed ID: 21077736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-4 and -10 exacerbate candidiasis in mice.
    Tonnetti L; Spaccapelo R; Cenci E; Mencacci A; Puccetti P; Coffman RL; Bistoni F; Romani L
    Eur J Immunol; 1995 Jun; 25(6):1559-65. PubMed ID: 7614983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4+ T-helper-cell responses in mice with low-level Candida albicans infection.
    Mencacci A; Spaccapelo R; Del Sero G; Enssle KH; Cassone A; Bistoni F; Romani L
    Infect Immun; 1996 Dec; 64(12):4907-14. PubMed ID: 8945525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel Th cell epitope of Candida albicans mediates protection from fungal infection.
    Bär E; Gladiator A; Bastidas S; Roschitzki B; Acha-Orbea H; Oxenius A; LeibundGut-Landmann S
    J Immunol; 2012 Jun; 188(11):5636-43. PubMed ID: 22529294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination with recombinant N-terminal domain of Als1p improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral, immunity.
    Ibrahim AS; Spellberg BJ; Avenissian V; Fu Y; Filler SG; Edwards JE
    Infect Immun; 2005 Feb; 73(2):999-1005. PubMed ID: 15664943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Candida and candidiasis in HIV-infected patients: where commensalism, opportunistic behavior and frank pathogenicity lose their borders.
    Cassone A; Cauda R
    AIDS; 2012 Jul; 26(12):1457-72. PubMed ID: 22472853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective antigens and mechanisms of anti-Candida immunity.
    Antonio C
    Nihon Ishinkin Gakkai Zasshi; 2000; 41(4):219. PubMed ID: 11064318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IFN-gamma is required for IL-12 responsiveness in mice with Candida albicans infection.
    Cenci E; Mencacci A; Del Sero G; d'Ostiani CF; Mosci P; Bacci A; Montagnoli C; Kopf M; Romani L
    J Immunol; 1998 Oct; 161(7):3543-50. PubMed ID: 9759875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T helper cell type 1 (Th1)- and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development.
    Cenci E; Mencacci A; Spaccapelo R; Tonnetti L; Mosci P; Enssle KH; Puccetti P; Romani L; Bistoni F
    J Infect Dis; 1995 May; 171(5):1279-88. PubMed ID: 7751704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type 1 T helper cells specific for Candida albicans antigens in peripheral blood and vaginal mucosa of women with recurrent vaginal candidiasis.
    Piccinni MP; Vultaggio A; Scaletti C; Livi C; Gomez MJ; Giudizi MG; Biagiotti R; Cassone A; Romagnani S; Maggi E
    J Infect Dis; 2002 Jul; 186(1):87-93. PubMed ID: 12089666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silencing SOCS1 in dendritic cells promote survival of mice with systemic Candida albicans infection via inducing Th1-cell differentiation.
    Shi D; Li D; Wang Q; Kong X; Mei H; Shen Y; Liu W
    Immunol Lett; 2018 May; 197():53-62. PubMed ID: 29581081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-protective TH1 immunity against Aspergillus fumigatus and Candida albicans.
    Stuehler C; Khanna N; Bozza S; Zelante T; Moretti S; Kruhm M; Lurati S; Conrad B; Worschech E; Stevanović S; Krappmann S; Einsele H; Latgé JP; Loeffler J; Romani L; Topp MS
    Blood; 2011 Jun; 117(22):5881-91. PubMed ID: 21441461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucosal and systemic T helper cell function after intragastric colonization of adult mice with Candida albicans.
    Bistoni F; Cenci E; Mencacci A; Schiaffella E; Mosci P; Puccetti P; Romani L
    J Infect Dis; 1993 Dec; 168(6):1449-57. PubMed ID: 8245528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Host responses to Candida albicans: Th17 cells and mucosal candidiasis.
    Conti HR; Gaffen SL
    Microbes Infect; 2010 Jul; 12(7):518-27. PubMed ID: 20381638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection.
    Sher A; Gazzinelli RT; Oswald IP; Clerici M; Kullberg M; Pearce EJ; Berzofsky JA; Mosmann TR; James SL; Morse HC
    Immunol Rev; 1992 Jun; 127():183-204. PubMed ID: 1354651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of protective Th1 responses to Candida albicans by antifungal therapy alone or in combination with an interleukin-4 antagonist.
    Cenci E; Mencacci A; Del Sero G; Bistoni F; Romani L
    J Infect Dis; 1997 Jul; 176(1):217-26. PubMed ID: 9207370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Silenced suppressor of cytokine signaling 1 (SOCS1) enhances the maturation and antifungal immunity of dendritic cells in response to Candida albicans in vitro.
    Shi D; Li D; Yin Q; Qiu Y; Yan H; Shen Y; Lu G; Liu W
    Immunol Res; 2015 Mar; 61(3):206-18. PubMed ID: 25381480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic and mucosal immunization with Candida albicans hsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis.
    Raska M; Belakova J; Horynova M; Krupka M; Novotny J; Sebestova M; Weigl E
    Med Mycol; 2008 Aug; 46(5):411-20. PubMed ID: 18608941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice.
    Li Wq; Hu Xc; Zhang X; Ge Y; Zhao S; Hu Y; Ashman RB
    Vaccine; 2011 Jul; 29(33):5526-33. PubMed ID: 21645574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of a genetically engineered Candida albicans tet-NRG1 strain as an experimental live attenuated vaccine against hematogenously disseminated candidiasis.
    Saville SP; Lazzell AL; Chaturvedi AK; Monteagudo C; Lopez-Ribot JL
    Clin Vaccine Immunol; 2009 Mar; 16(3):430-2. PubMed ID: 19144791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.